Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Gelone

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Annals of Pharmacotherapy|December 31, 2002
Caspofungin acetate for treatment of invasive fungal infectionsStaci A Pacetti, Steven P Gelone
Infectious Disease Clinics of North America|August 17, 2004
The newer fluoroquinolonesJudith A O'Donnell, Steven P Gelone
Antimicrobial Agents and Chemotherapy|July 21, 2022
Tissue Distribution of [<sup>14</sup>C]-Lefamulin into the Urogenital Tract in RatsWolfgang W Wicha, Claire Henson, Kathryn Webbley, et al.
Open Forum Infectious Diseases|July 12, 2021
A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant <i>S. pneumoniae</i> in Ambulatory and Hospitalized Adult Patients in the United StatesVikas Gupta, Kalvin C Yu, Jennifer Schranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2019
Reply to Tang and LaiThomas M File, Steven P Gelone, Jennifer Schranz, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 2, 2024
Physiologically-based pharmacokinetic modeling of the drug-drug interaction between ivacaftor and lefamulin in cystic fibrosis patientsMagali Amiel, Alice Ke, Steven P Gelone, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2019
Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosingWolfgang W Wicha, William T Prince, Claudia Lell, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015-2016)Susanne Paukner, Steven P Gelone, S J Ryan Arends, et al.
Plos One|September 29, 2021
Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse modelMichael Hafner, Susanne Paukner, Wolfgang W Wicha, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance MechanismsRodrigo E Mendes, Susanne Paukner, Timothy B Doyle, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Annals of Pharmacotherapy|December 31, 2002
Caspofungin acetate for treatment of invasive fungal infectionsStaci A Pacetti, Steven P Gelone
Infectious Disease Clinics of North America|August 17, 2004
The newer fluoroquinolonesJudith A O'Donnell, Steven P Gelone
Antimicrobial Agents and Chemotherapy|July 21, 2022
Tissue Distribution of [<sup>14</sup>C]-Lefamulin into the Urogenital Tract in RatsWolfgang W Wicha, Claire Henson, Kathryn Webbley, et al.
Open Forum Infectious Diseases|July 12, 2021
A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant <i>S. pneumoniae</i> in Ambulatory and Hospitalized Adult Patients in the United StatesVikas Gupta, Kalvin C Yu, Jennifer Schranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2019
Reply to Tang and LaiThomas M File, Steven P Gelone, Jennifer Schranz, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 2, 2024
Physiologically-based pharmacokinetic modeling of the drug-drug interaction between ivacaftor and lefamulin in cystic fibrosis patientsMagali Amiel, Alice Ke, Steven P Gelone, et al.
The Journal of Antimicrobial Chemotherapy|April 6, 2019
Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosingWolfgang W Wicha, William T Prince, Claudia Lell, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015-2016)Susanne Paukner, Steven P Gelone, S J Ryan Arends, et al.
Plos One|September 29, 2021
Anti-inflammatory activity of lefamulin versus azithromycin and dexamethasone in vivo and in vitro in a lipopolysaccharide-induced lung neutrophilia mouse modelMichael Hafner, Susanne Paukner, Wolfgang W Wicha, et al.
Antimicrobial Agents and Chemotherapy|January 24, 2019
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results during the SENTRY Surveillance Program for 2015-2016 and Characterization of Resistance MechanismsRodrigo E Mendes, Susanne Paukner, Timothy B Doyle, et al.
Pageof 3